Pj. Nestel et al., Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women, J CLIN END, 84(3), 1999, pp. 895-898
The possibility that the heightened cardiovascular risk associated with the
menopause can be reduced by increasing dietary isoflavone intake was teste
d in 17 women by measuring arterial compliance, an index of the elasticity
of large arteries such as the thoracic aorta. Compliance diminishes with ag
e and menopause.
An initial 3- to 4-week run-in period and a 5-week placebo period were foll
owed by two 6-week periods of active treatment with 40 mg and then 80 mg is
oflavones derived from red clover containing genistein, daidzein, biochanin
, and formononetin in 14 and 13 women, respectively, with 3 others serving
as placebo controls throughout. Arterial compliance, measured by ultrasound
as a pressure (carotid artery) and volume (outflow into aorta) relationshi
p, was determined after each period; plasma lipids were measured twice duri
ng each period. Urinary output of isoflavones was also determined.
Arterial compliance rose by 23% relative to that during the placebo period
with the 80-mg isoflavone dose and slightly less with the 40-mg dose (mean
+/- SEM: placebo, 19.7 +/-: 1.5; 40 mg, 23.7 +/- 0.7; 80 mg, 24.4 +/- 1.4).
In the three women receiving continuous placebo, compliance was 16 +/- 2.2
, similar to that during the run-in period for the remaining subjects (17 /- 2.1). ANOVA showed a significant (P = < 0.001) difference between treatm
ents; by Bonferroni multiple comparisons and by paired t test, differences
were significant between placebo and 40- and 80-mg isoflavone doses (by pai
red t test: P = 0.039 for placebo vs. 40 mg; P = 0.018 for placebo us. 80 m
g). Plasma lipids were not significantly affected.
An important cardiovascular risk factor, arterial compliance, which diminis
hes with menopause, was significantly improved with red clover isoflavones.
As diminished compliance leads to systolic hypertension and may increase l
eft ventricular work, the findings indicate a potential new therapeutic app
roach for improved cardiovascular function after menopause.